loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 2283417 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 LANREOTIDE (LANREOTIDE ACETATE) (1)

filter

01 IPSEN BIOPHARMACEUTICALS CANADA INC (1)

filter

01 SOLUTION (EXTENDED RELEASE) (1)

filter

01 120MG/SYR (1)

filter

01 Canada (1)

URL Supplier Web Content
SOLUTION (EXTENDED REL...
120MG/SYR
SOMATULINE AUTOGEL
Canada
2283417
120MG/SYRINGE
Prescription
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 2283417

Looking for CTD TGA MCC DOSSIER APPLICATION 2283417 1

19

Ipsen, based in France, is a pharmaceutical company.

One of their notable products is LANREOTIDE (LANREOTIDE ACETATE), with a corresponding application number 2283417 and regulatory information .

proudly manufactured in the

Ipsen's SOMATULINE AUTOGEL SOLUTION (EXTENDED RELEASE), medication with 120MG/SYR of LANREOTIDE (LANREOTIDE ACETATE).

Post Enquiry
POST ENQUIRY